FIELD: pharmacology.
SUBSTANCE: invention relates to novel functionalized thienoindole derivatives of the formula 
and it's pharmaceutically acceptable salts which can be used to prepare a medicament for the treatment of cancer.
EFFECT: increased efficiency of compound application.
4 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW ALKYLATING AGENTS | 2013 |
|
RU2632206C2 |
| ASYMMETRIC METHOD FOR PRODUCING THIENO-INDOLE DERIVATIVES | 2016 |
|
RU2726638C2 |
| BIFUNCTION CYTOTOXIC AGENTS CONTAINING PHARMACOPHORE CTI | 2016 |
|
RU2682645C1 |
| BIFUNCTIONAL CYTOTOXIC AGENTS | 2015 |
|
RU2669807C2 |
| FUNCTIONALISED DERIVATIVES OF MORPHOLINYLANTHRACYCLINE | 2015 |
|
RU2715902C2 |
| NEW CONJUGATES BINDING COMPOUND - ACTIVE COMPOUND (ADC) AND USE THEREOF | 2012 |
|
RU2610336C2 |
| ANTIBODY AND DRUG CONJUGATES (ADC) AND ANTIBODY AND PRODRUG CONJUGATES (APDC) CONTAINING ENZYMATICALLY CLEAVABLE GROUPS | 2016 |
|
RU2751512C2 |
| SULFONAMIDE-CONTAINING BINDING SYSTEMS FOR MEDICINAL CONJUGATES | 2014 |
|
RU2729194C2 |
| DERIVATIVES OF CARBOXYLIC ACIDS (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FO SELECTIVE BINDING αβ-INTEGRIN IN MAMMAL | 2000 |
|
RU2263109C2 |
| NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE | 2019 |
|
RU2809547C2 |
